摘要
采用PCR-RFLP对120例Graves病(GD)复发患者(停药3年内复发85例,3年后复发35例),66例GD初发患者和100例健康对照的细胞毒性T淋巴细胞相关抗原4(CTLA-4)基因A/G多态性进行检测。结果提示,CTLA-4第1外显子49位点A/G多态性在中国北方汉族人不仅与GD发生相关,而且影响GD停药后缓解的持续时间,与早期复发相关。
The A/G polymorphism of cytotoxic T lymphocyte associated antiger 4 (CTLA-4) was determined by PCR-RFLP in 120 patients with recurrent Graves' disease (GD), including 85 cases with early relapses within 3 years and 35 cases with relapses more than 3 years after withdrawal of antithyroid medication. 66 initial GD patients and 100 healthy controls were included in the present study. The results suggest that A/G polymorphism of CTLA-4 was associated not only with GD, but also with early relapes after withdrawal of antithyroid medication.
出处
《中华内分泌代谢杂志》
CAS
CSCD
北大核心
2008年第2期192-193,共2页
Chinese Journal of Endocrinology and Metabolism